Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Astragalus plus Notoginseng granule with losartan for early diabetic nephropathy
ChiCTR1900023531Phase 4Not yet recruiting
- Sponsor
- Shanghai Sixth People's Hospital East Campus
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in diabetic glomerulosclerosis comparing Losartan alone with Astragalus plus Notoginseng granule combined with losartan (2 arms). Primary endpoints: 24-hour urinary protein quantification, Albumin-to-creatinine ratio and 4 more. Planned start Sep 2019; status: not yet recruiting.
02
Drugs
astragalus + notoginseng granulelosartan
03
Conditions
diabetic glomerulosclerosis
Beyond the preview
Go deeper on ChiCTR1900023531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900023531.